Total Funding
56
60
Total FundingVenture - Series Unknown raised
Growth Score 56 in past quarter
-12 pts
Heat Score 60 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
81468
CDx Diagnostics develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells.
- Mark Rutenberg: Founder and Chief Scientific Officer
- William Huffnagle: Chief Executive Officer
About the Company
CDx develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells. It offers OralCDx, an accurate and non-invasive biopsy to evaluate common oral lesions to rule out dysplasia or cancer, prevention of cancer of the oral cavity, pharynx, larynx, and esophagus through early detection of their easily treatable
and pre-cancerous precursors. It provides these tests and systems nationally to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists.